The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPEMV.L Regulatory News (PEMV)

  • There is currently no data for PEMV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Prospectus

3 Oct 2014 17:18

RNS Number : 4633T
Pembroke VCT PLC
03 October 2014
 

Pembroke VCT plc

New share offer

Following the success of its first offer of Ordinary Shares, the Board of Pembroke VCT plc (the "Company") is pleased to confirm proposals (the "Proposals") for a new B Ordinary Share offer (the "Offer") of up to 25 million B Ordinary Shares, with an over-allotment facility of up to 10 million B Ordinary Shares.

The Company has today published a circular (the "Circular") to shareholders convening a shareholder general meeting (the "General Meeting") to be held at 3 Cadogan Gate, London SW1X 0AS at 3.00pm on 3 November 2014 at which resolutions will be put to Ordinary Shareholders to approve (a) the creation of the new B Ordinary Shares and the adoption of new articles of association to provide for the new share class, (b) the issue of the new B Ordinary Shares, (c) the adoption of the performance incentive arrangements in respect of the new B Ordinary Shares; (d) the payment of a promoter fee in relation to the B Ordinary Share Offer and (e) the granting of authority to the directors of the Company to buy back B Ordinary Shares in the market.

The Company has also today published a prospectus (the "Prospectus") in relation to the Offer of the new B Ordinary Shares. Both the Circular and Prospectus will be sent to existing shareholders. Copies of the Circular and Prospectus are available from Oakley Investment Managers LLP, 3 Cadogan Gate, London SW1X 0AS, 0207 766 6900.

The B Ordinary Shares would be a separate class of share, distinct from the existing Ordinary Shares, and with distinct rights to a separate pool of assets and liabilities. It is expected that the new share offer will be available for subscription from 3 October 2014, conditional on shareholder approval at the General Meeting, inviting investment in either or both of the 2014/15 and 2015/16 tax years.

Subject to shareholder approval at the General Meeting, the Offer of B Ordinary Shares is expected to become unconditional with effect from 3 November 2014 (the date of the General Meeting) and will close not later than 12.00pm on 2 April 2015 in respect of the 2014/2015 Offer and not later than 5.00pm on 1 September 2015 in respect of the 2015/2016 Offer, or as soon as the Offer is fully subscribed. The Directors, in their absolute discretion may decide to close the Offer early. Application has been made for the admission of the new B Ordinary Shares to listing on the premium section of the UKLA's Official List and to trading on the main market of the London Stock Exchange. It is expected that new B Ordinary Shares will be issued throughout the period of the Offer until it closes.

As stated above, at the General Meeting the Company will seek shareholder approval for (i) the payment of a promoter's fee to Palmer Capital LLP (being a commission of 2.0 % of the aggregate value of accepted applications for the B Ordinary Shares received under the Offer) and (ii) the Company entering into an amendment agreement to the existing investment management agreement with Oakley Investment Managers LLP (the investment manager of the Company) in relation to the new performance incentive in respect of the B Ordinary Shares. In relation to these matters, Palmer Capital LLP and Oakley Investment Managers LLP respectively is each considered a related party of the Company under the Listing Rules.

The first offer was launched in February 2013 and closed for subscriptions in January 2014. Together with a subsequent top-up offer, the Company raised in excess of £18 million. To date the Company has invested £12.5 million to a diverse portfolio of 19 investments and expects to be fully invested later this year.

The Proposals are intended to benefit both existing Ordinary Shareholders and new B Ordinary Shareholders by ring-fencing the assets and liabilities relating to each share class which should avoid any dilution of the rights of the existing Ordinary Shareholders in respect of the existing invested portfolio.

Subscription for new B Ordinary Shares in the Company will provide the B Shareholders with access to a private equity type investment strategy, replicating the existing approach of the Company, whilst benefiting from the tax benefits available to investors in VCTs.

A copy of the Prospectus is available, free of charge, from the registered office of the Company.

Copies of the Prospectus will be submitted to the National Storage Mechanism and will shortly be available for viewing online at the following website:

http://www.morningstar.co.uk/uk/NSM

For further information, please contact:

Pembroke VCT plc+44 (0) 20 7766 6900Peter Dubens / Andrew Wolfson

The City Partnership (UK) Limited, Company Secretary+44 (0) 131 243 7210Robin Smeaton

FTI Consulting+44 (0) 20 7831 3113Edward Bridges / Emily Hartman

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEUOANRSOARRAA
Date   Source Headline
26th Aug 20201:35 pmRNSResult of Conversion of Shares
26th Aug 20207:30 amRNSSuspension of listing of ordinary shares
14th Aug 202011:46 amRNSResults of General and Ord Share class Meetings
4th Aug 20209:14 amRNSIntention to launch an offer for subscription
24th Jul 20203:39 pmRNSDividend Declaration
24th Jul 20203:38 pmRNSAnnual Financial Report
16th Jul 20202:57 pmRNSCirc re. Amendment to Articles
1st May 20209:29 amRNSTotal Voting Rights
14th Apr 202012:01 pmRNSIssue of Equity
6th Apr 20201:42 pmRNSIssue of Equity
3rd Apr 20205:13 pmRNSOffer for subscription closing date
1st Apr 20207:51 amRNSTotal Voting Rights
20th Mar 20204:59 pmRNSIssue of Equity
19th Mar 20201:58 pmRNSNet Asset Value(s)
2nd Mar 20204:20 pmRNSIssue of Equity
27th Feb 202011:28 amRNSOffer for subscription - over allotment facility
3rd Feb 202011:00 amRNSTotal Voting Rights
21st Jan 20203:35 pmRNSIssue of Equity
15th Jan 20205:13 pmRNSOffer for Subscription - over-allotment facility
18th Dec 20198:19 amRNSIssue of Equity
16th Dec 20194:15 pmRNSHolding(s) in Company
13th Dec 20193:21 pmRNSHalf-year Report
2nd Dec 20194:24 pmRNSTotal Voting Rights
8th Nov 20195:09 pmRNSIssue of Equity
31st Oct 20194:08 pmRNSIssue of Equity
16th Oct 20194:07 pmRNSOffer for subscription update
1st Oct 20194:22 pmRNSDirector/PDMR Shareholding
30th Sep 20195:33 pmRNSIssue of Equity
27th Sep 20198:16 amRNSResult of GM
27th Sep 20198:15 amRNSResult of AGM
23rd Sep 20194:36 pmRNSRelated party transaction
2nd Sep 20191:28 pmRNSPublication of Prospectus and Circular
1st Aug 201910:35 amRNSTotal Voting Rights
29th Jul 20195:17 pmRNSDividend Declaration
29th Jul 20195:15 pmRNSAnnual Financial Report
16th Jul 20199:39 amRNSIntention to launch an offer for subscription
5th Jul 20191:08 pmRNSIssue of Equity
4th Jun 20199:15 amRNSOffer for subscription closing date
3rd Jun 20191:19 pmRNSTotal Voting Rights
16th May 20194:39 pmRNSIssue of Equity
1st May 201912:18 pmRNSTotal Voting Rights
15th Apr 20192:40 pmRNSIssue of Equity - replacement
8th Apr 20194:08 pmRNSIssue of Equity
5th Apr 20197:59 amRNSOffer for subscription over allotment facility
2nd Apr 20193:04 pmRNSIssue of Equity
29th Mar 20194:20 pmRNSTransaction in Own Shares
1st Mar 20198:45 amRNSTotal Voting Rights
22nd Feb 201911:25 amRNSIssue of Equity
14th Dec 201811:42 amRNSHalf-year Report
13th Dec 20182:23 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.